Novel HIV-1 non-nucleoside reverse transcriptase inhibitors: a patent review (2011 – 2014)
Author:
Publisher
Informa Healthcare
Subject
Drug Discovery,Pharmacology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.1517/13543776.2014.964685
Reference94 articles.
1. Antiviral Drug Resistance and the Need for Development of New HIV-1 Reverse Transcriptase Inhibitors
2. In search of a treatment for HIV – current therapies and the role of non-nucleoside reverse transcriptase inhibitors (NNRTIs)
3. New therapeutic landscape of NNRTIs for treatment of HIV: a look at recent data
4. Structure-Activity Relationship Studies on Clinically Relevant HIV-1 NNRTIs
5. Etravirine
Cited by 48 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Synthesis and anti‐HIV activity of non‐nucleoside reverse‐transcriptase inhibitor DB02 phosphate derivatives based on water‐soluble optimization;Drug Development Research;2023-02-08
2. Current medicinal chemistry strategies in the discovery of novel HIV-1 ribonuclease H inhibitors;European Journal of Medicinal Chemistry;2022-12
3. Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses;Bioorganic & Medicinal Chemistry;2021-07
4. Method Development and Validation for Multicomponent Analysis of Emtricitabine and Ritonavir in Bulk Drug by RP-HPLC;Journal of Drug Delivery and Therapeutics;2020-11-30
5. Discovery and optimization of benzenesulfonamides-based hepatitis B virus capsid modulators via contemporary medicinal chemistry strategies;European Journal of Medicinal Chemistry;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3